Patent · US Active

Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose

US9757329B2 · kind B2 · utility

7Cited by

4References

18Claims

0Family size

Assignee

IPSEN BIOPHARM LIMITED · GB

Inventors

Paul Webb · Leeds, GB
Mary White · Lake Jackson, US
Julie Partington · Wrexham, GB

Key dates

Filing date	Jul 28, 2015
Grant date	Sep 12, 2017
Priority date	—
Expiry date	Jul 28, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a solid or liquid pharmaceutical composition comprising botulinum neurotoxin complex (type A, B, C, D, E, F or G) or high purity botulinum neurotoxin (type A, B, C, D, E, F or G), and a surfactant. In particular the invention relates to a solid or liquid pharmaceutical composition comprising a crystalline agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.